Intervention

IPL344

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

2 shown

A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IVNCT03755167 · 2018-12-09

A Study of IPL344 in the Treatment of ALS PatientsNCT03652805 · 2018-08-01

Common conditions

Amyotrophic Lateral Sclerosis1 Amyotrophic Lateral Sclerosis (ALS)1

Leading sponsors

Immunity Pharma Ltd.2

Trial status mix

SUSPENDED2

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.